XML 76 R63.htm IDEA: XBRL DOCUMENT

LOSS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2021

LOSS PER SHARE

Schedule of Basic and Diluted Income Per Share

A reconciliation of net loss attributable to the Company in the consolidated statements of comprehensive loss to the numerator for the computation of basic and diluted loss per share for the years ended December 31, 2019, 2020 and 2021 is as follows:


		For the Years Ended December 31,
		2019		2020		2021		2021
		RMB		RMB		RMB		US$

Net loss attributable to Concord Medical Services Holdings Limited		(307,049)		(309,989)		(271,427)		(42,594)
Accretion of contingently redeemable noncontrolling interests		(245,477)		(359,920)		(549,194)		(86,181)
Numerator for EPS computation		(552,526)		(669,909)		(820,621)		(128,775)


		For the Years Ended December 31
		2019				2020				2021				2021
		Class A		Class B		Class A		Class B		Class A		Class A		Class B		Class B
		RMB		RMB		RMB		RMB		RMB		USD		RMB		USD
Numerator
Net loss attributable to ordinary shareholders used in calculating loss per ordinary share – basic and diluted		(358,274)		(194,252)		(435,855)		(234,054)		(533,909)		(83,784)		(286,712)		(44,991)
Denominator:
Weighted average number of ordinary shares outstanding used in calculating loss per share – basic and diluted		84,450,550		45,787,948		85,265,910		45,787,948		85,265,910		85,265,910		45,787,948		45,787,948
Loss per share – basic and diluted		(4.24)		(4.24)		(5.11)		(5.11)		(6.26)		(0.98)		(6.26)		(0.98)

The effects of share options and restricted shares have been excluded from the computation of diluted loss per share for the years ended December 31, 2019, 2020 and 2021 as their effects would be anti-dilutive.